EXTR Q4 2025 Earnings Transcript

Delek reported adjusted EBITDA of $170.2 million, up from $107 million in the prior quarter, and raised its EOP run-rate benefit target to $130 million-$170 million after achieving $30 million of improvement in the quarter. The company also generated $51 million of operating cash flow, returned $29 million to shareholders via dividends and buybacks, and kept DKL 2025 EBITDA guidance at $480 million-$520 million. Offsetting the progress, Delek posted a $106 million GAAP net loss and continues to face uncertainty around pending Small Refinery Exemption petitions.

Analysis

The market is starting to price DK less like a high-beta refiner and more like a sum-of-parts catalyst with an embedded self-help story. The key second-order effect is that every incremental EOP dollar improves not just near-term equity cash flow, but also the credibility of a structural separation of DKL, which can compress the conglomerate discount faster than the underlying earnings base grows. That matters because the valuation rerate can arrive well before any regulatory resolution, especially if management continues to prove that cash generation is becoming less cyclical and more repeatable.

The biggest hidden winner is DKL, not DK: liquidity plus third-party growth reduces dependence on the parent and makes a monetization path more financeable. A more independent DKL also changes the negotiating power with potential buyers or strategic partners, because the asset is no longer being priced as a captive subsidiary. For competitors, this is a subtle negative for other midsize inland refiners and gathering systems because DK is effectively using operational discipline to outgrow its discount, making it harder for peers to argue for similar multiple expansion without comparable self-help.

The principal risk is that the market confuses guided benefits with durable earnings power. The company is effectively bridging a P&L gap with optimization, working capital, and a better crack backdrop; if margin normalization or a diesel demand wobble hits over the next 1-2 quarters, the perception of progress can stall quickly. The unresolved regulatory overhang remains binary, but the more immediate catalyst is execution on Q3 throughput and whether the Liberty/Libby ramp creates enough temporary cost pressure to dent the cash conversion story before the separation narrative gains traction.

Consensus likely underestimates how much of the rerating can happen without a final SRE decision. The contrarian setup is that the cleaner the DKL story becomes, the more the market may stop waiting for the headline binary and instead value the standalone assets on a better comparable basis. That creates upside even if the legal issue remains unresolved for months, but it also means the stock becomes more sensitive to any evidence that EOP benefits are front-loaded rather than recurring.

Key Decisions for Investors

• Long DK vs. short a basket of inland refiners (e.g., DK/PSX or DK/HFC) for 1-3 months: thesis is DK’s self-help and separation optionality should outperform peers that lack a visible catalyst; stop if Q3 throughput/margin guidance rolls over.
• Add to DKL on pullbacks over the next 2-6 weeks: the liquidity improvement and third-party business mix shift should support a higher midstream multiple; risk/reward is favorable as long as leverage stays contained and distribution coverage holds.
• Buy DK Jan-2026 call spreads to express the SRE/separation catalyst without fully underwriting regulatory timing: upside can come from multiple expansion before a legal decision; downside is capped if the process drags.
• Avoid chasing DK after strength; prefer entry only on post-earnings consolidation or any selloff tied to temporary Libby 2 ramp costs: the next leg depends on proof that EOP is recurring, not just a one-quarter benefit.